Critical

Meconium aspiration syndrome (MAS) in the newborn – delivery-room & ongoing management

Meconium-stained respiratory failure · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

MAS is respiratory distress in a meconium-stained infant with characteristic chest radiograph changes, caused by airway obstruction, chemical pneumonitis, surfactant inactivation and often pulmonary hypertension. Routine intrapartum/oropharyngeal suctioning and routine tracheal suction of vigorous babies are NOT recommended; management is supportive with escalation as needed.

Red flags

  • Rapid desaturation suggesting pneumothorax
  • Large pre/post-ductal SpO2 gradient indicating PPHN
  • Rising oxygenation index despite optimal ventilation
  • Refractory hypotension or shock
  • Persistent acidosis or lactataemia

Assessment

Differential diagnosis

  • Transient tachypnoea of the newborn
  • Respiratory distress syndrome (if preterm)
  • Congenital/early-onset pneumonia or sepsis
  • Persistent pulmonary hypertension of the newborn
  • Pneumothorax or air leak
  • Congenital heart disease

Investigations

  • Chest radiograph (patchy asymmetric infiltrates, hyperinflation, air leaks)
  • Arterial blood gas and pre/post-ductal SpO2
  • Full blood count, CRP and blood culture
  • Blood glucose, electrolytes and lactate
  • Echocardiography if PPHN suspected or oxygenation poor
  • Oxygenation index trending if ventilated

Management

  • At birth, follow standard NLS/NRP: if the baby is vigorous, do NOT perform tracheal suction – dry, stimulate and assess.
  • If the baby is non-vigorous (apnoeic/poor tone) and not responding, prioritise effective ventilation; consider direct laryngoscopy and tracheal suction only if the airway is obstructed, without delaying ventilation.
  • Provide supplemental oxygen titrated to targeted pre-ductal SpO2; avoid both hypoxia and hyperoxia.
  • Admit to NICU for continuous monitoring; obtain chest radiograph and blood gas.
  • Support breathing: CPAP for moderate distress; intubate and ventilate for respiratory failure, using strategies that minimise barotrauma given air-leak risk.
  • Maintain adequate mean airway pressure/lung recruitment; consider gentle ventilation or HFOV for severe disease.
  • Give surfactant for significant parenchymal disease/oxygenation failure; consider surfactant lavage in refractory cases.
  • Start empirical antibiotics after cultures because pneumonia cannot be excluded.
  • Screen for and treat PPHN (pre/post-ductal gradient, echocardiography) with inhaled nitric oxide if indicated.
  • Maintain normal temperature, glucose, calcium, systemic BP and adequate sedation/analgesia.
  • Watch closely for pneumothorax; have equipment for emergency drainage ready.
  • Escalate to ECMO referral for severe refractory hypoxaemic respiratory failure.

Drugs & doses

Poractant alfa (surfactant) 100–200 mg/kg intratracheal for significant parenchymal disease
Inhaled nitric oxide 20 ppm, weaned as tolerated, for associated PPHN
Benzylpenicillin 50 mg/kg IV 12-hourly plus gentamicin 5 mg/kg IV every 36 h (empirical sepsis cover)
Morphine 10–20 microgram/kg/hour IV infusion for sedation while ventilated
Dopamine 5–20 microgram/kg/min IV to support systemic BP in PPHN

Disposition

NICU admission with capacity for ventilation, iNO and air-leak drainage; early discussion with a surfactant/ECMO centre for severe or refractory disease.

Complications & pitfalls

  • Pneumothorax and other air leaks
  • Persistent pulmonary hypertension of the newborn
  • Surfactant inactivation and secondary pneumonia
  • Chronic lung changes after severe disease
  • Hypoxic-ischaemic injury from severe hypoxaemia
  • Air trapping and ventilator-associated injury

Exam pearls

  • Routine intrapartum and delivery-room suctioning of meconium is no longer recommended – ventilation comes first.
  • A sudden deterioration in a ventilated MAS baby is a pneumothorax until proven otherwise.
  • PPHN frequently coexists – obtain pre/post-ductal saturations early.
  • Use lung-protective ventilation given the high air-leak risk.
  • Antibiotics are reasonable because pneumonia and MAS are clinically indistinguishable early.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.